79 related articles for article (PubMed ID: 30501426)
1. CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels.
Ray B; Ozcagli E; Sadee W; Wang D
Pharmacogenet Genomics; 2019 Feb; 29(2):39-47. PubMed ID: 30520769
[TBL] [Abstract][Full Text] [Related]
2. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
3. Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy.
Danek PJ; Wójcikowski J; Daniel WA
Toxicol Appl Pharmacol; 2020 Nov; 406():115239. PubMed ID: 32941854
[TBL] [Abstract][Full Text] [Related]
4. The Engagement of Cytochrome P450 Enzymes in Tryptophan Metabolism.
Haduch A; Bromek E; Kuban W; Daniel WA
Metabolites; 2023 May; 13(5):. PubMed ID: 37233670
[TBL] [Abstract][Full Text] [Related]
5.
Hassen LM; Daghestani MH; Omair MA; Althomali AK; Almukaynizi FB; Almaghlouth IA
Saudi Med J; 2023 Mar; 44(3):237-245. PubMed ID: 36940959
[TBL] [Abstract][Full Text] [Related]
6. Cocaine-Induced Time-Dependent Alterations in Cytochrome P450 and Liver Function.
Jastrzębska J; Daniel WA
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675146
[TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia.
Dzhaubermezov M; Ekomasova N; Mustafin R; Gabidullina L; Galimova Y; Nurgalieva A; Valova Y; Prokofyeva D; Khusnutdinova E
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553620
[TBL] [Abstract][Full Text] [Related]
8. The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain.
Haduch A; Bromek E; Pukło R; Jastrzębska J; Danek PJ; Daniel WA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430225
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics in Psychiatry Practice: The Value and the Challenges.
Alchakee A; Ahmed M; Eldohaji L; Alhaj H; Saber-Ayad M
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362270
[TBL] [Abstract][Full Text] [Related]
10. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression analysis following olfactory learning in honeybee (Apis mellifera L.).
Fahad Raza M; Anwar M; Husain A; Rizwan M; Li Z; Nie H; Hlaváč P; Ali MA; Rady A; Su S
PLoS One; 2022; 17(2):e0262441. PubMed ID: 35139088
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
13. CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study.
Just KS; Dormann H; Freitag M; Schurig M; Böhme M; Steffens M; Scholl C; Seufferlein T; Graeff I; Schwab M; Stingl JC
Front Pharmacol; 2021; 12():624104. PubMed ID: 34025403
[TBL] [Abstract][Full Text] [Related]
14. Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances.
Sheng Y; Yang H; Wu T; Zhu L; Liu L; Liu X
Front Pharmacol; 2021; 12():650027. PubMed ID: 33967789
[TBL] [Abstract][Full Text] [Related]
15. Biogenic amine neurotransmitters promote eicosanoid production and protein homeostasis.
Joshi KK; Matlack TL; Pyonteck S; Vora M; Menzel R; Rongo C
EMBO Rep; 2021 Mar; 22(3):e51063. PubMed ID: 33470040
[TBL] [Abstract][Full Text] [Related]
16. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid hormones differentially regulate CYP2D in female wild-type and CYP2D6-humanized mice.
Konstandi M; Andriopoulou CE; Cheng J; Gonzalez FJ
J Endocrinol; 2020 May; 245(2):301-314. PubMed ID: 32171179
[TBL] [Abstract][Full Text] [Related]
19. The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders.
Haduch A; Daniel WA
Drug Metab Rev; 2018 Nov; 50(4):415-429. PubMed ID: 30501426
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
